
Professor of Neurology. Vice Chair, Neurology Research. Headache Specialist. Mayo Clinic Arizona. President @ahsheadache
Joined November 2010
- Tweets968
- Following315
- Followers2.9K
- Likes813
Todd Schwedt, M.D., FAHS retweeted
Free Access:
🧠@ahsheadache releases a position statement recommending annual #migraine #WomensHealth screening, from adolescence through menopause.
Timely diagnosis can transform care & outcomes.
🔗headachejournal.onlinelibrar…
@schwedtt @AmaalStarlingMD @HersheyAndrew @SengElizabeth
Todd Schwedt, M.D., FAHS retweeted
The AHS Scientific Program Committee is accepting late-breaking abstract submissions for 2025 #AHSAM. Abstracts should be an original contribution on any #headache-related topic. Learn more about late-breaking abstract submissions and submit by April 30: bit.ly/3PqACmo
Todd Schwedt, M.D., FAHS retweeted
AHS is now accepting abstracts for the 67th #AHSAM, June 19–22, 2025, in Minneapolis, MN! Accepted abstracts will be published in the @HeadacheJournal.
Learn more and submit by Feb. 26th here: bit.ly/3PqACmo
Todd Schwedt, M.D., FAHS retweeted
#ArtificialIntelligence terminology, methodology, & critical appraisal: Authors share a primer for #headache clinicians & researchers
headachejournal.onlinelibrar…
@ChiaChunChiang @p_f_zhang @MiaMinenMD @FredCohenMD et al
Todd Schwedt, M.D., FAHS retweeted
The @ahsheadache First Contact Program has been an effective initiative with most #PrimaryCare participants reporting intention to implement key practice changes to improve care for patients with #headache
headachejournal.onlinelibrar…
@MiaMinenMD @NinaRiggins @adamsprouseblum
Todd Schwedt, M.D., FAHS retweeted
Clinical and biological features associate with migraine treatment responses. Research that validates and expands upon existing findings in clinical settings is needed to achieve precision medicine for migraine treatment.
Precision medicine for migraine aims to tailor treatments based on individual patient characteristics, potentially speeding up the process of finding effective, tolerable therapies.
Clinical, genomic, proteomic, physiologic, and brain imaging markers may predict how well patients respond to acute and preventive migraine treatments.
Further research is needed to develop predictive models for treatment responses, helping clinicians choose the best treatment options for each patient.
journals.sagepub.com/doi/10.…
#headache #migraine #neurology
Todd Schwedt, M.D., FAHS retweeted
Join over 2,300 #headache colleagues and become a member of AHS! Access cutting-edge research, resources, free CME opportunities, the @HeadacheJournal, and more. Current members- renew for 2025 and continue enjoying your exclusive benefits! Join or renew: bit.ly/joinAHS
Todd Schwedt, M.D., FAHS retweeted
Grant opportunity for AHS members! AHS is seeking applications that will fund up to $50,000 to support investigator-initiated research projects on #migraine and #headache. View criteria and apply by Dec. 2: bit.ly/3Bv7pTh #NeuroTwitter
Todd Schwedt, M.D., FAHS retweeted
Happy #NationalAPPWeek!
If you are a NP, PA or other APP who cares for patients with #Headache disorders, please join our professional society @ahsheadache - connect with colleagues, stay up to date in practice and engage in activities that benefit our patients and the field!
Happy National Advanced Practice Providers Week! Thank you to APP’s for your dedication to #headachemedicine.
Co-Chairs of the AHS APP Special Interest Group, Drs. @EhrlichNP & Laura Xanders have a special message to share in honor of this recognition week.
Want to join the AHS community? Learn more here: bit.ly/joinAHS #NationalAPPWeek
Todd Schwedt, M.D., FAHS retweeted
Last day to register at the early-bird rate for #AHSAZ!
Last chance to take advantage of early-bird pricing for 2024 #AHSAZ! Join members of the #headache community for practical, clinical, and evidence-based information on diagnosing, treating, and managing headache disorders. Register today: bit.ly/4dpZGUx #NeuroTwitter
Todd Schwedt, M.D., FAHS retweeted
Apply today for the 2025 International #HeadacheAcademy! Join us Feb 20-22 in Los Angeles, CA. Open to PGY-3+ Residents, Fellows, and clinicians/researchers in the US, Canada, & Latin America. View full eligibility criteria and apply by Oct 27: bit.ly/3zoqLc4 #HeadacheMedicine
Todd Schwedt, M.D., FAHS retweeted
We spoke to @AmynahPradhan about the recently published @ahsheadache #headache research priorities! Listen to the interview linked below to find out the details behind this important work.
Free access manuscript: headachejournal.onlinelibrar…
youtu.be/-zAKWygJuko
Todd Schwedt, M.D., FAHS retweeted
The AHS Scottsdale Program Co-Chairs, Drs. Dougherty, Friedman, and Powers invite you to attend the upcoming 2024 #AHSAZ, November 14-17! Take a look at the video to learn more about what's ahead. Join us and register here today: bit.ly/4dpZGUx #NeuroTwitter
Todd Schwedt, M.D., FAHS retweeted
Don't miss your chance to apply for the 2024 AHS Emerging Leaders Program! This initiative supports early-career professionals in #headachemedicine. Learn more and apply by Sept. 1 here: bit.ly/46w5FF7 #EmergingAHS #NeuroTwitter #MedEd
Todd Schwedt, M.D., FAHS retweeted
Free Access:
The @ahsheadache & an international multistakeholder expert group published #headache research priorities to help guide investigators over the next 10 yrs & and serve as benchmarks to measure progress over time
headachejournal.onlinelibrar…
@schwedtt @AmynahPradhan et al
Todd Schwedt, M.D., FAHS retweeted
Congratulations to the #fellows and programs who participated in #HeadacheMatch 2024! Interested in #HeadacheMedicine? Visit the AHS National Headache Medicine Fellowship website to learn more: bit.ly/3Vh4pQ2 #FellowMatch @NRMP
Todd Schwedt, M.D., FAHS retweeted
Today is #HeadacheMatch Day! Excited to hear about all of the incoming 2025 Fellows!! Please share your excitement- post, tag and let us all know!!! @ahsheadache @AANmember @TheNRMP #meded #headache #migraine #cluster #concussion
Todd Schwedt, M.D., FAHS retweeted
I was fortunate to participate in #EmergingAHS 2022-2023 🙏
This program opens up doors and opportunities for further mentorship and collaboration in #Headache and with our society. If you are early career and this is your path, do not miss the chance to participate!
Applications for the 2024 AHS Emerging Leaders Program are now open through Sept. 1st! #EmergingAHS encourages early-career medical professionals to thrive in #headachemedicine and within the Society. View full application criteria and apply here: bit.ly/46w5FF7
Todd Schwedt, M.D., FAHS retweeted
I'm thrilled to share our latest article on #AI Applications in #Headache. We discussed how #AI can be used to facilitate diagnosis and personalized treatments 🧠 Keiko Ihara @DumkriegerG @p_f_zhang Tzubasa Takizawa @schwedtt @MayoClinicNeuro
🔗 rdcu.be/dNaqq
Todd Schwedt, M.D., FAHS retweeted
Exciting News! The 2023 Journal Citation Report by Clarivate is out, and we're thrilled to share that the @HeadacheJournal’s Impact Factor has risen to 5.4! Thanks to all contributors, reviewers, and readers for your support! View more here: bit.ly/4bn9o8C




















